trial
as of 2026-07-01fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
NCTId NCT04798131
at a glance
— · Recruiting
Enrollment 84 (estimated)
Sponsored by University Hospital, Lille
Primary completion 2026-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
84 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2022-08-26
Primary completion
2026-07
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
University Hospital, LilleLead Sponsor
National Research Agency, FranceCollaborator
Investigators
1
Renaud JARDRI, MD,PhDPrincipal Investigator
Sites
1 total
Lille, France
Facts & assertions
4 sourced
Enrollment
84
Phase
NA
Primary Completion Date
2026-07
Status
RECRUITING
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator
person